Mier JW - Search Results

1

Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.

Liu Q, Mier JW, Panka DJ. Liu Q, et al. Among authors: mier jw. Mol Cancer. 2021 Jun 15;20(1):92. doi: 10.1186/s12943-021-01378-8. Mol Cancer. 2021. PMID: 34130704 Free PMC article. No abstract available.

2

Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.

Liu Q, Mier JW, Panka DJ. Liu Q, et al. Among authors: mier jw. Mol Cancer. 2011 Sep 19;10:115. doi: 10.1186/1476-4598-10-115. Mol Cancer. 2011. Retraction in: Mol Cancer. 2021 Jun 15;20(1):92. doi: 10.1186/s12943-021-01378-8 PMID: 21929745 Free PMC article. Retracted.

3

Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.

Panka DJ, Liu Q, Geissler AK, Mier JW. Panka DJ, et al. Among authors: mier jw. Mol Cancer. 2013 Mar 5;12:17. doi: 10.1186/1476-4598-12-17. Mol Cancer. 2013. Retraction in: Mol Cancer. 2021 Jun 11;20(1):89. doi: 10.1186/s12943-021-01379-7 PMID: 23497256 Free PMC article. Retracted.

4

Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells.

Panka DJ, Liu Q, Geissler AK, Mier JW. Panka DJ, et al. Among authors: mier jw. Mol Cancer. 2021 Jun 11;20(1):89. doi: 10.1186/s12943-021-01379-7. Mol Cancer. 2021. PMID: 34116693 Free PMC article. No abstract available.

5

Effect of melanoma on immune function in the regional lymph node basin.

Negin B, Panka D, Wang W, Siddiqui M, Tawa N, Mullen J, Tahan S, Mandato L, Polivy A, Mier J, Atkins M. Negin B, et al. Clin Cancer Res. 2008 Feb 1;14(3):654-9. doi: 10.1158/1078-0432.CCR-07-1577. Clin Cancer Res. 2008. PMID: 18245524

6

The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cells.

Panka DJ, Wang W, Atkins MB, Mier JW. Panka DJ, et al. Among authors: mier jw. Cancer Res. 2006 Feb 1;66(3):1611-9. doi: 10.1158/0008-5472.CAN-05-0808. Cancer Res. 2006. Retraction in: Cancer Res. 2019 Oct 15;79(20):5459. doi: 10.1158/0008-5472.CAN-19-2621 PMID: 16452220 Retracted.

7

Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.

Panka DJ, Atkins MB, Mier JW. Panka DJ, et al. Among authors: mier jw. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2371s-2375s. doi: 10.1158/1078-0432.CCR-05-2539. Clin Cancer Res. 2006. PMID: 16609061 Review.

8

GSK-3beta inhibition enhances sorafenib-induced apoptosis in melanoma cell lines.

Panka DJ, Cho DC, Atkins MB, Mier JW. Panka DJ, et al. Among authors: mier jw. J Biol Chem. 2008 Jan 11;283(2):726-32. doi: 10.1074/jbc.M705343200. Epub 2007 Nov 8. J Biol Chem. 2008. PMID: 17991738 Free article.

9

The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.

Cho DC, Cohen MB, Panka DJ, Collins M, Ghebremichael M, Atkins MB, Signoretti S, Mier JW. Cho DC, et al. Among authors: mier jw. Clin Cancer Res. 2010 Jul 15;16(14):3628-38. doi: 10.1158/1078-0432.CCR-09-3022. Epub 2010 Jul 6. Clin Cancer Res. 2010. PMID: 20606035 Free PMC article.

10

Assaying for BRAF V600E in tissue and blood in melanoma.

Panka DJ, Mier JW, Sullivan RJ. Panka DJ, et al. Among authors: mier jw. Methods Mol Biol. 2014;1102:117-36. doi: 10.1007/978-1-62703-727-3_8. Methods Mol Biol. 2014. PMID: 24258977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters